Literature DB >> 28365260

CXCL12 as a Predictor of Vitiligo Activity and Disease Progression.

Vitali Alexeev1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28365260     DOI： 10.1016/j.jid.2017.03.020

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  4 in total

1.  Chemokines in Vitiligo Pathogenesis: CXCL10 and 12.

Authors:  Khaled Gharib; Hend Gadallah; Ayman Elsayed
Journal:  J Clin Aesthet Dermatol       Date:  2021-09

2.  Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome.

Authors:  M El-Domyati; W H El-Din; A F Rezk; I Chervoneva; J B Lee; M Farber; J Uitto; O Igoucheva; Vitali Alexeev
Journal:  Arch Dermatol Res       Date:  2021-04-17       Impact factor: 3.017

Review 3.  The Promising Role of Chemokines in Vitiligo: From Oxidative Stress to the Autoimmune Response.

Authors:  Shan He; Jinhua Xu; Jinfeng Wu
Journal:  Oxid Med Cell Longev       Date:  2022-01-19       Impact factor: 6.543

4.  Skin Interstitial Fluid and Plasma Multiplex Cytokine Analysis Reveals IFN-γ Signatures and Granzyme B as Useful Biomarker for Activity, Severity and Prognosis Assessment in Vitiligo.

Authors:  Chau Yee Ng; Yen-Chuan Chiu; Yu-Pei Chan; Yu-Jr Lin; Pei-Han Chung; Wen-Hung Chung; Cheng-Lung Ku
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.